Finance

Lists
BOLT:NASDAQ
Bolt Biotherapeutics Inc
$3.26
+2.60%
(+0.083) 1D
$3.32
+1.84% (+0.060)
After hours
Closed: Aug 19, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BOLT...
Open
$3.29
High
$3.31
Low
$3.18
Mkt. cap
6.27M
Avg. vol.
20.96K
Volume
21.15K
52-wk high
$7.09
52-wk low
$3.13
EPS
-$16.44
Beta
1.18
Shares outstanding
1.93M
No. of employees
23
Open
$3.29
High
$3.31
Low
$3.18
Mkt. cap
6.27M
Avg. vol.
20.96K
Volume
21.15K
52-wk high
$7.09
52-wk low
$3.13
EPS
-$16.44
Beta
1.18
Shares outstanding
1.93M
No. of employees
23
News stories
From web sources and news partners
About Bolt Biotherapeutics Inc
CEO-
Employees23
Founded2015
HeadquartersRedwood City, California, United States
SectorBiotechnology
Websiteboltbio.com
Analyst ratings
Based on 3 analysts giving stock ratings to BOLT in the past 3 months
Buy
Buy
2
Hold
1
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for BOLT in the last 3 months.
Highest
Current $3.26
$22.00 (+574.85%)
Average
$14.50 (+344.79%)
Lowest
$7.00 (+114.72%)
Analyst
Recommendation
Action
Price target
Projected
Date
Boris Peaker
JonesTrading
Hold
Reiterated
-
-
08/12/2026
Michael King
Rodman & Renshaw
Buy
Initiated
$22.00
+574.8%
05/28/2026
Robert Burns
H.C. Wainwright
Buy
Reiterated
$7.00
+114.7%
05/28/2026
Chad Messer
Lake Street
Buy
Maintained
$75.00
+2,200.6%
05/13/2026
Unknown Analyst
JonesTrading
Hold
Maintained
-
-
04/06/2026
Last report
Aug 11, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
-$4.57 / -$21.06
+78.30%beat
Revenue / Est. (USD)
5.00K / 500.00K
-99.00%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
2.17M
2.50M
26.00K
5.00K
Cost of goods sold
6.54M
4.99M
4.59M
5.15M
Cost of revenue
6.54M
4.99M
4.59M
5.15M
Research and development expenses
-
-
242.00K
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.34M
3.12M
2.80M
2.42M
Operating expense
3.34M
3.12M
3.04M
2.42M
Total operating expenses
9.87M
8.10M
7.63M
7.57M
Operating income
-7.70M
-5.60M
-7.60M
-7.57M
Other non operating income
82.00K
87.00K
81.00K
476.00K
EBT including unusual items
-7.14M
-6.63M
-7.24M
-7.72M
EBT excluding unusual items
-7.14M
-5.15M
-7.24M
-6.91M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-7.14M
-6.63M
-7.24M
-7.72M
Net profit margin
-329.37%
-265.24%
-27,861.54%
-154,400.00%
Earnings per share
-3.72
-2.98
-4.31
-4.57
Interest and investment income
477.00K
367.00K
276.00K
178.00K
Interest expense
-
-
-
-
Net interest expenses
477.00K
367.00K
276.00K
178.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-7.41M
-5.35M
-7.40M
-7.40M
Gain or loss from assets sale
-
-
-31.00K
-373.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps